ICU Medical Insiders Sell US$1.0m Of Stock, Possibly Signalling Caution
ICU Medical Insiders Sell US$1.0m Of Stock, Possibly Signalling Caution
Over the last year, we can see that the biggest insider sale was by the Chief Operating Officer, Christian Voigtlander, for US$884k worth of shares, at about US$130 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$85.47. So it may not shed much light on insider confidence at current levels. Over the past year, many ICU Medical, Inc. (NASDAQ:ICUI) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more.
在過去的一年中，許多ICU Medical, Inc.（納斯達克股票代碼：ICUI）內部人士出售了該公司的大量股份，這可能激起了投資者的興趣。在評估內幕交易時，了解內部人士是買入還是賣出通常更有利，因爲後者可能有多種解釋。但是，如果有許多內部人士出售，股東應該進行更多調查。
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
雖然我們絕不會建議投資者僅根據公司董事的所作所爲做出決定，但邏輯要求你應該注意內部人士是在買入還是賣出股票。
See our latest analysis for ICU Medical
查看我們對 ICU Medical 的最新分析
The Last 12 Months Of Insider Transactions At ICU Medical
ICU Medical 最近 12 個月的內幕交易
Over the last year, we can see that the biggest insider sale was by the Chief Operating Officer, Christian Voigtlander, for US$884k worth of shares, at about US$130 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$85.47. So it may not shed much light on insider confidence at current levels.
在過去的一年中，我們可以看到，最大的內幕出售是首席運營官克里斯蒂安·沃伊特蘭德，以價值88.4萬美元的股票出售，每股約130美元。雖然我們通常不喜歡看到內幕拋售，但更令人擔憂的是銷售是否以較低的價格進行。令人欣慰的是，此次出售的價格遠高於目前的股價，即85.47美元。因此，在目前的水平上，它可能無法爲內部人士的信心提供太多啓示。
ICU Medical insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
去年，ICU Medical內部人士沒有購買任何股票。你可以在下面看到過去 12 個月內幕交易（由公司和個人進行的）的直觀描述。點擊下圖，你可以看到每筆內幕交易的確切細節！
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
如果你像我一樣，那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。
Insiders At ICU Medical Have Sold Stock Recently
ICU Medical 的內部人士最近出售了股票
The last three months saw significant insider selling at ICU Medical. Specifically, insider Daniel Woolson ditched US$152k worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.
在過去的三個月中，ICU Medical進行了大量的內幕拋售。具體而言，內部人士丹尼爾·伍爾森在那段時間拋售了價值15.2萬美元的股票，我們沒有記錄任何買入。這可能表明一些內部人士認爲這些股票並不便宜。
Insider Ownership
內部所有權
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. ICU Medical insiders own 5.7% of the company, currently worth about US$118m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
我喜歡看看內部人士在一家公司擁有多少股份，以幫助我了解他們與內部人士的一致性。我認爲，如果內部人士擁有該公司的大量股份，那將是一個好兆頭。ICU Medical內部人士擁有該公司5.7％的股份，按最近的股價計算，目前價值約爲1.18億美元。內部人士持有這種重大所有權通常會增加公司爲所有股東的利益而經營的機會。
What Might The Insider Transactions At ICU Medical Tell Us?
ICU Medical 的內幕交易可能會告訴我們什麼？
An insider hasn't bought ICU Medical stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing ICU Medical. In terms of investment risks, we've identified 1 warning sign with ICU Medical and understanding it should be part of your investment process.
在過去的三個月中，有內部人士沒有買入ICU Medical的股票，但有一些人賣出。而且在過去的一年中，沒有任何可以給我們帶來安慰的購買。很高興看到內幕所有權很高，但內幕拋售使我們謹慎行事。除了了解正在進行的內幕交易外，確定ICU Medical面臨的風險也是有益的。在投資風險方面，我們已經確定了ICU Medical的1個警告信號，並認爲這應該成爲您投資過程的一部分。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
當然，通過尋找其他地方，你可能會找到一筆不錯的投資。因此，來看看這份有趣的公司的免費清單吧。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言，內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益，不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎？對內容感到擔憂？直接聯繫我們。 或者，給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論，我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議，也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意，我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之，華爾街沒有持有任何上述股票的頭寸。